FR2510606B1 - - Google Patents

Info

Publication number
FR2510606B1
FR2510606B1 FR8114842A FR8114842A FR2510606B1 FR 2510606 B1 FR2510606 B1 FR 2510606B1 FR 8114842 A FR8114842 A FR 8114842A FR 8114842 A FR8114842 A FR 8114842A FR 2510606 B1 FR2510606 B1 FR 2510606B1
Authority
FR
France
Prior art keywords
capsular
polyosides
bacteriae
give
retained material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8114842A
Other languages
English (en)
French (fr)
Other versions
FR2510606A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BERRI BALZAC
Original Assignee
BERRI BALZAC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BERRI BALZAC filed Critical BERRI BALZAC
Priority to FR8114842A priority Critical patent/FR2510606A1/fr
Priority to IE1705/82A priority patent/IE53582B1/en
Priority to AT82401343T priority patent/ATE16244T1/de
Priority to DE8282401343T priority patent/DE3267160D1/de
Priority to EP82401343A priority patent/EP0071515B1/fr
Priority to DK327182A priority patent/DK327182A/da
Priority to PT75301A priority patent/PT75301B/pt
Priority to CA000408233A priority patent/CA1206905A/en
Priority to NO822592A priority patent/NO159394C/no
Priority to DD82242065A priority patent/DD202623A5/de
Priority to ES514496A priority patent/ES514496A0/es
Publication of FR2510606A1 publication Critical patent/FR2510606A1/fr
Application granted granted Critical
Publication of FR2510606B1 publication Critical patent/FR2510606B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8114842A 1981-07-30 1981-07-30 Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins Granted FR2510606A1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR8114842A FR2510606A1 (fr) 1981-07-30 1981-07-30 Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
IE1705/82A IE53582B1 (en) 1981-07-30 1982-07-15 Process for the production of capsular polyosides,capsular polyosides obtained thereby,and their application to the preparation of vaccines
AT82401343T ATE16244T1 (de) 1981-07-30 1982-07-19 Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen.
DE8282401343T DE3267160D1 (en) 1981-07-30 1982-07-19 Process for producing capsular polyosides, capsular polyosides so obtained and their use in the preparation of vaccines
EP82401343A EP0071515B1 (fr) 1981-07-30 1982-07-19 Procédé d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application à la préparation de vaccins
DK327182A DK327182A (da) 1981-07-30 1982-07-21 Indkapslede polyoxider og fremgangsmaade til fremstilling deraf
PT75301A PT75301B (fr) 1981-07-30 1982-07-23 Procede d'obtention de polyosides capsulaires appliques a la preparation de vaccins
CA000408233A CA1206905A (en) 1981-07-30 1982-07-28 Process for the production of capsular polyosides and capsular polyosides obtained thereby
NO822592A NO159394C (no) 1981-07-30 1982-07-28 Fremgangsmaate for fremstilling av immunogene kapselformede polyosider fra kapselbakterier.
DD82242065A DD202623A5 (de) 1981-07-30 1982-07-29 Verfahren zur herstellung von sporen-polyosiden
ES514496A ES514496A0 (es) 1981-07-30 1982-07-29 "un procedimiento de obtencion de poliosidos capsulares inmunogenos".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8114842A FR2510606A1 (fr) 1981-07-30 1981-07-30 Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins

Publications (2)

Publication Number Publication Date
FR2510606A1 FR2510606A1 (fr) 1983-02-04
FR2510606B1 true FR2510606B1 (enExample) 1984-10-26

Family

ID=9261011

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8114842A Granted FR2510606A1 (fr) 1981-07-30 1981-07-30 Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins

Country Status (11)

Country Link
EP (1) EP0071515B1 (enExample)
AT (1) ATE16244T1 (enExample)
CA (1) CA1206905A (enExample)
DD (1) DD202623A5 (enExample)
DE (1) DE3267160D1 (enExample)
DK (1) DK327182A (enExample)
ES (1) ES514496A0 (enExample)
FR (1) FR2510606A1 (enExample)
IE (1) IE53582B1 (enExample)
NO (1) NO159394C (enExample)
PT (1) PT75301B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0238739B1 (en) * 1986-03-27 1992-02-05 Swiss Serum and Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
CN100529054C (zh) * 2000-03-16 2009-08-19 费城儿童医院 调节肺炎球菌荚膜多糖的生产
NZ511680A (en) 2001-05-14 2004-07-30 Univ Waikato Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases
GB0522303D0 (en) * 2005-11-01 2005-12-07 Chiron Srl Culture method
WO2008129559A2 (en) 2007-04-23 2008-10-30 Serum Institute Of India Ltd Antigenic polysaccharides and process for their preparation
WO2011148382A1 (en) 2010-05-28 2011-12-01 Biological E Limited An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol.
WO2011151841A1 (en) * 2010-05-31 2011-12-08 Panacea Biotec Limited Fermentation process for streptococcus pneumoniae
KR20240110660A (ko) 2016-12-30 2024-07-15 박사이트, 인코포레이티드 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
CA3267399A1 (en) 2022-09-19 2024-03-28 Biological E Ltd PROCESS FOR THE PURIFICATION OF CAPSULAR POLYSACCHARIDES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166963A (en) * 1936-11-19 1939-07-25 Sharp & Dohme Inc Antigenic polysaccharide complex
US2528972A (en) * 1947-05-15 1950-11-07 Western Reserve University Prophylactic toxoid compound and method of making same
FR2407262A1 (fr) * 1977-10-27 1979-05-25 Cassenne Lab Sa Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4307080A (en) * 1979-09-24 1981-12-22 Merck & Co., Inc. Meningitis vaccine
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries

Also Published As

Publication number Publication date
DK327182A (da) 1983-01-31
NO822592L (no) 1983-01-31
CA1206905A (en) 1986-07-02
ES8305827A1 (es) 1983-04-16
EP0071515B1 (fr) 1985-10-30
FR2510606A1 (fr) 1983-02-04
NO159394B (no) 1988-09-12
IE53582B1 (en) 1988-12-21
IE821705L (en) 1983-01-30
ES514496A0 (es) 1983-04-16
DE3267160D1 (en) 1985-12-05
ATE16244T1 (de) 1985-11-15
PT75301B (fr) 1984-07-31
DD202623A5 (de) 1983-09-28
EP0071515A1 (fr) 1983-02-09
PT75301A (fr) 1982-08-01
NO159394C (no) 1988-12-21

Similar Documents

Publication Publication Date Title
FR2510606B1 (enExample)
AU8211187A (en) Improved process for transforming plant protoplasts
ATE91155T1 (de) Verfahren zur bereitung von nukleinsaeure fuer hybridisierung.
DE69114311D1 (de) Verfahren zur Herstellung und Extrahierung von Antioxydantien aus einer Mikroorganismenkultur und Fotobioreaktor zur Durchführung des Verfahrens.
ATE68211T1 (de) Verfahren zur kontinuierlichen herstellung von l- carnitin.
ATE18776T1 (de) Verfahren und vorrichtung zur zuechtung von mikroorganismen.
NO875319L (no) Fremgangsmaate for ekstracellulaer fremstilling av homopolysakkarider.
DE69109886D1 (de) Verfahren zur Herstellung von humanem Faktor VIII und dessen Analogen.
DE3369158D1 (en) Biologically active ws 6049 substances, a process for the production thereof and their pharmaceutical compositions
FR2545099B1 (fr) Nouvelle souche de trichoderma harzianum procede d'isolement de cette souche, procede de culture de cette souche, nouveaux peptides produits par cette souche, et application de cette souche et ces nouveaux peptides ou du produit obtenu par le procede de culture comme moyen de lutte biologique sous forme de produit phytosanitaire
EP0307373A3 (en) Purification process
DE3065316D1 (en) Process for the production of creatinine iminohydrolase by growing micro-organism and nutrient medium for the practice of said process
ATE9100T1 (de) Trichosporon kashiwayama ifo 1964, kulturbruehe, zell-freie sterile fluessigkeit, steriles filtrat, steriler ueberstand, steriles konzentrat und steriles trockenprodukt einer kulturbruehe, verfahren zur herstellung einer kulturbruehe, pharmazeutische zusammensetzung, kosmetische zusammensetzung.
WO1990010058A3 (en) Method for production and purification of hepatitis b vaccine
JPS5675095A (en) Preparation of heat-resistant acetic acid kinase
ATE21033T1 (de) Verfahren zur herstellung eines immunogens aus pasteurella multocida.
RU94025893A (ru) Способ выделения биологически активных веществ
JPS5554898A (en) Preparation of 3-o-demethyl-fortimicin a
JPS55102389A (en) Novel microorganism
FR2655659B1 (fr) Procede propre a inhiber la croissance des microorganismes dans un milieu de culture avant son utilisation, milieu ainsi obtenu et son application a la culture des bifidobacteries.
JPS54154713A (en) Derivative of glucosamine
JPS56124381A (en) Preparation of uricase by fermentation method
JPS5687594A (en) Antibiotic substance xk-209 and its preparation
RO94493A2 (ro) Procedeu de preparare a unui mediu de cultivare a bacteriilor anaerobe
JPS55165799A (en) Preparation of hopan-22-ol and hopene-b

Legal Events

Date Code Title Description
ST Notification of lapse